Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Acorda Therapeutics, Inc. (NQ: ACOR)
32.94 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Acorda Therapeutics, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Acorda Therapeutics to Present at the UBS Global Life Sciences Conference
September 12, 2011
from Business Wire News Releases
Acorda Therapeutics Statement on ZANAFLEX CAPSULES® Patent Litigation
September 07, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2011
from Business Wire News Releases
Acorda Therapeutics Joins NY BioHud Valley as Founding Member
August 15, 2011
from Business Wire News Releases
Acorda Therapeutics Announces Allowance of Second U.S. Patent Application for AMPYRA® Covering Methods of Use for Improving Walking in Multiple Sclerosis
August 10, 2011
from Business Wire News Releases
Acorda Therapeutics Chief Scientific Officer Andrew R. Blight Recognized among PharmaVOICE’s 100 Most Inspiring People
August 02, 2011
from Business Wire News Releases
Acorda Therapeutics Reports Second Quarter 2011 Financial Results
August 01, 2011
from Business Wire News Releases
Biogen Idec obtiene aprobación condicional en la Unión Europea de FAMPYRA® para mejorar la capacidad de caminar de los pacientes adultos con esclerosis múltiple
July 26, 2011
from Business Wire Spanish
Biogen Idec Receives Conditional Approval in the European Union for FAMPYRA® to Improve Walking in Adults with Multiple Sclerosis
July 25, 2011
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Discuss Second Quarter 2011 Financial Results on August 1, 2011
July 25, 2011
from Business Wire News Releases
Acorda Therapeutics Licenses Rights to Investigational Treatment for Spinal Cord Injury and Traumatic Brain Injury
July 01, 2011
from Business Wire News Releases
Acorda Therapeutics Wins Telly Awards in Documentary and Public Relations Categories
June 30, 2011
from Business Wire News Releases
Acorda Therapeutics to Relocate Corporate Headquarters to Ardsley Park Life Science Campus; Site Acquired and Now Managed by BioMed Realty Trust
June 27, 2011
from Business Wire News Releases
Acorda Therapeutics Wins Two 2011 Stevie Awards at the 9th Annual American Business Awards
June 24, 2011
from Business Wire News Releases
New Clinical Data Analysis of AMPYRA® (Dalfampridine) Shows Improvement of Patient-Reported Walking Ability across a Range of Walking Impairment
June 06, 2011
from Business Wire News Releases
Acorda Therapeutics Statement on CHMP Positive Opinion on Marketing Authorization Application for FAMPYRA® in Europe
May 20, 2011
from Business Wire News Releases
Acorda Therapeutics Recognized as One of the Best Places to Work in New York State
May 09, 2011
from Business Wire News Releases
Acorda Therapeutics Reports First Quarter 2011 Financial Results
May 05, 2011
from Business Wire News Releases
Acorda Therapeutics Ranked Fifth in The Scientist Best Places to Work in Industry 2011 Survey
April 28, 2011
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report First Quarter 2011 Financial Results on May 5, 2011
April 28, 2011
from Business Wire News Releases
Acorda Therapeutics Announces Changes to Board of Directors
April 20, 2011
from Business Wire News Releases
Acorda Therapeutics Announces Allowance of U.S. Patent Application for AMPYRA® (dalfampridine) Covering Methods of Use for Improving Walking in Multiple Sclerosis
April 19, 2011
from Business Wire News Releases
NASDAQ $ Gainers in Review by StockMister.com : ACOR, ITMN, LUFK, SINA, OYOG, VRTS
April 18, 2011
from EmailWire.Com Press Releases
NASDAQ Percentage Gainers in Focus from StockMister.com : PEDH, ACOR, CHINA, NYNY, CYBI, RPRX
April 18, 2011
from EmailWire.Com Press Releases
Acorda Therapeutics Presents New AMPYRA® (dalfampridine) Data Analyses on Walking Improvement in Multiple Sclerosis at AAN Annual Meeting
April 11, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the Cowen & Company 31st Annual Health Care Conference
February 28, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the Citi 2011 Global Health Care Conference
February 22, 2011
from Business Wire News Releases
Acorda Therapeutics Reports Fourth Quarter and Full Year 2010 Financial Results
February 17, 2011
from Business Wire News Releases
Acorda Therapeutics to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
February 15, 2011
from Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on February 17, 2011
February 10, 2011
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here